Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multidisciplinary Medication Approach for Gait Difficulty in Parkinson's Disease
NCT02857244Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Nov 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine, donepezil, modafinil in Parkinson's disease (PD), progressive supranuclear palsy (PSP), sponsored by University of Chicago. Planned start Nov 2016; status: withdrawn.
02
Drugs
duloxetinedonepezilmodafinil
03
Conditions
Parkinson's disease (PD)progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT02857244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857244.